TBPH EBITDA Growth
Theravance Biopharma Inc · EBITDA Growth
TBPH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported48.54%period ending
TBPH TTM EBITDA YoY % (-53.26% → 48.54%)
Year-over-year change
High-resolution chart · PNG
TBPH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 48.5369% | |
| 453.6621% | |
| 472.3131% | |
| 255.81% | |
| 248.278% | |
| -20.6137% | |
| 22.7137% | |
| 36.5722% | |
| 48.0206% | |
| 47.8737% | |
| 30.9525% | |
| 41.6885% | |
| 53.639% | |
| 57.0541% | |
| 66.5523% | |
| 62.3102% | |
| 49.2748% | |
| 43.8766% | |
| 19.899% | |
| -3.4378% | |
| -10.8048% | |
| -25.9884% | |
| -25.3304% | |
| -20.7098% | |
| -15.6706% | |
| 1.0529% | |
| 4.1594% | |
| 18.6965% | |
| 19.184% | |
| 19.2291% | |
| 18.0217% | |
| -0.3925% | |
| -17.7301% | |
| -36.5888% | |
| -45.7895% | |
| -36.6773% | |
| -12.8129% | |
| -5.6955% | |
| 0.8661% | |
| 7.2803% | |
| 5.296% | |
| 11.6048% | |
| 21.7931% | |
| 8.8998% | |
| 1.7092% | |
| -14.1552% | |
| -49.2309% | |
| -49.7487% | |
| -53.2632% |